Disclosure

Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 4, 2008, Pages 483-485

  Rosenfeld, Richard M ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; EDITORIAL; FINANCIAL MANAGEMENT; HEALTH CARE PERSONNEL; INTERVENTION STUDY; LAW ENFORCEMENT; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; PUBLICATION; SOCIOLOGY;

BIAS (EPIDEMIOLOGY); CONFLICT OF INTEREST; DISCLOSURE; EDITORIAL POLICIES; HUMANS; RESEARCH DESIGN; WIT AND HUMOR AS TOPIC;

EID: 52249090904     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2008.08.001     Document Type: Editorial

References (15)

1. Choudhry N.K., Stelfox H.T., and Detsky A.S. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287 (2002) 612-617
2. Drazen J.M., and Curfman G.D. Financial associations of authors [editorial]. New Eng J Med 346 (2002) 1902-2
3. Wiktionary. http://en.wiktionary.org/wiki/disclosure Accessed July 28, 2008
4. Scopus. http://www.scopus.com Accessed July 28, 2008
5. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. http://www.icmje.org Accessed July 28, 2008
6. In: Last J.M., Spasoff R.A., Harris S.S., and Thuriaux M.C. (Eds). A Dictionary of Epidemiology. 4th ed. (2001), Oxford University Press, New York 14-16
7. Editorial commentary: avoiding biased comparisons. The James Lind Library 2007. http://www.jameslindlibrary.org Accessed July 28, 2008
8. Grimes D.A., and Schulz K.F. Bias and causal associations in observational research. Lancet 359 (2002) 248-252
9. Fries J.F., and Krishnan E. Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development. Arthritis Res Ther 6 (2004) R250-R255
10. Bekelman J.E., Li Y., and Gross C.P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289 (2003) 454-465
11. Lexchin J., Bero L.A., Djulbegovic B., et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326 (2003) 1167-1170
12. Kjaergard L.L., and Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials. BMJ 325 (2002) 249-251
13. Smith R. Beyond conflict of interest: transparency is the key. BMJ 317 (1998) 291-292
14. Detsky A.S. Sources of bias for authors of clinical practice guidelines. CMAJ 175 (2006) 1033
15. Surowiecki J. The talking cure. The New Yorker December 9, 2002;38. http://www.newyorker.com/archive Accessed July 27, 2008